Abstract
Perturbation of the gut-associated microbial community may underlie many human illnesses, but the mechanisms that maintain homeostasis are poorly understood. We found that the depletion of butyrate-producing microbes by antibiotic treatment reduced epithelial signaling through the intracellular butyrate sensor peroxisome proliferator-activated receptor γ (PPAR-γ). Nitrate levels increased in the colonic lumen because epithelial expression of Nos2, the gene encoding inducible nitric oxide synthase, was elevated in the absence of PPAR-γ signaling. Microbiota-induced PPAR-γ signaling also limits the luminal bioavailability of oxygen by driving the energy metabolism of colonic epithelial cells (colonocytes) toward β-oxidation. Therefore, microbiota-activated PPAR-γ signaling is a homeostatic pathway that prevents a dysbiotic expansion of potentially pathogenic Escherichia and Salmonella by reducing the bioavailability of respiratory electron acceptors to Enterobacteriaceae in the lumen of the colon.
Copyright © 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Angiopoietin-Like Protein 4 / genetics
-
Anilides / pharmacology
-
Animals
-
Anti-Bacterial Agents / pharmacology
-
Butyrates / metabolism
-
Caco-2 Cells
-
Clostridium / drug effects
-
Clostridium / metabolism
-
Colitis / metabolism
-
Colitis / microbiology
-
Colon / metabolism
-
Colon / microbiology
-
Dysbiosis / chemically induced
-
Dysbiosis / genetics
-
Dysbiosis / metabolism*
-
Dysbiosis / microbiology*
-
Enterobacteriaceae / metabolism
-
Enterobacteriaceae / pathogenicity*
-
Epithelial Cells / metabolism
-
Epithelial Cells / microbiology
-
Female
-
Gastrointestinal Microbiome*
-
Gene Expression
-
Homeostasis
-
Humans
-
Male
-
Mice
-
Mice, Inbred C57BL
-
Nitrates / metabolism
-
Nitric Oxide Synthase Type II / antagonists & inhibitors
-
Nitric Oxide Synthase Type II / genetics
-
Nitric Oxide Synthase Type II / metabolism*
-
Oxidation-Reduction
-
PPAR gamma / antagonists & inhibitors
-
PPAR gamma / genetics
-
PPAR gamma / metabolism*
-
Signal Transduction
-
Streptomycin / pharmacology
Substances
-
2-chloro-5-nitrobenzanilide
-
Angiopoietin-Like Protein 4
-
Anilides
-
Anti-Bacterial Agents
-
Butyrates
-
Nitrates
-
PPAR gamma
-
Nitric Oxide Synthase Type II
-
Streptomycin